Clinical trials in Gabon
80 studies list at least one site in Gabon. 11 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the studies in Gabon recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Most studied here
Who runs them
Centre de Recherche Médicale de Lambaréné (15) · Albert Schweitzer Hospital (9) · Novartis Pharmaceuticals (9) · Sanofi (6) · GlaxoSmithKline (5) · Medicines for Malaria Venture (4) · Barcelona Institute for Global Health (3) · Baylor College of Medicine (3)
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting2
First site in Gabon2
Results posted1
Studies
Recruiting first, then most recently updated. Showing 50 of 80 — search for more.
- A Phase 2A Study of a Novel Antimalarial Pyrrolidinamide in Adult Patients With Uncomplicated P. Falciparum MalariaRecruitingNCT07545681Phase 2
- Molecular Epidemiology, Strains Genotyping of Multi-drug Resistant Tuberculosis Circulating in Central Africa RegionRecruitingNCT07017803
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2)RecruitingNCT07811908Phase 2
- Artemisia Annua Infusion for the Treatment of Asymptomatic Plasmodium Falciparum InfectionNot yet recruitingNCT07819825Phase 1
- A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients)RecruitingNCT06422338Not applicable
- PanACEA - STEP2C -01RecruitingNCT05807399Phase 2
- Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking AfricaRecruitingNCT03803735
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum MalariaRecruitingNCT05750628Phase 2
- A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum CarriersRecruitingNCT05911828Phase 1
- A Crossover Bioavailability Clinical Trial of Parenteral Pyronaridine and ArtesunateNot yet recruitingNCT05929157Phase 1/2
- Seroepidemiological Investigation of Coronavirus 2019 (COVID-19) Infection in GabonRecruitingNCT05065632
- Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum MalariaCompletedNCT05842954Phase 3
- Variants of SARS-CoV-2 Causing COVID-19 in AfricaCompletedNCT05311891
- Controlled Human Malaria Infection by Mosquito Bites Using a Local Strain of Plasmodium FalciparumCompletedNCT07816497Phase 1
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B1)CompletedNCT07811882Phase 2
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B2)CompletedNCT07235033Phase 2
- Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum MalariaCompletedNCT04546633Phase 2
- Treatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug ResistanceCompletedNCT03057756
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum MalariaCompletedNCT07235020Phase 2
- Phase IIa Proof of Concept Study of M5717-Pyronaridine in Adults and Adolescents With Acute Uncomplicated Plasmodium Falciparum Malaria (CAPTURE 1)CompletedNCT05689047Phase 2
- Pan-Malaria Transmission-Blocking Vaccine AnAPN1CompletedNCT05905432Phase 1
- Monitoring COVID-19 Vaccination Response in Fragile PopulationsCompletedNCT05222139
- Evaluation of Efficacy and Safety of VPM1002 in Comparison to BCG in Prevention of Tb Infection in InfantsCompletedNCT04351685Phase 3
- Study of Co-administered Na-APR-1 (M74) and Na-GST-1 in Gabonese ChildrenCompletedNCT02839161Phase 1
- Improving Maternal heAlth by Reducing Malaria in African HIV WomenCompletedNCT03671109Phase 3
- Prevalence and Impact of COVID-19 on Maternal and Infant Health in African PopulationsCompletedNCT05303168
- Helminth Infection During Pregnancy on Vitamin D Regulation: HELMVIT StudyCompletedNCT04324853
- Evaluation of the VOT Among Tuberculosis Patients From LambarénéCompletedNCT05865626Not applicable
- Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, GabonCompletedNCT05130398Phase 1/2
- Important Data on COVID-19 Profile in AfricaCompletedNCT04847817
- Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum MalariaCompletedNCT00331136Phase 2
- To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine and Artefenomel in Adults and Children With Uncomplicated Plasmodium Falciparum MalariaTerminatedNCT02497612Phase 2
- Study to Investigate the Clinical and Parasiticidal Activity and Pharmacokinetics of Different Doses of Artefenomel and Ferroquine in Patients With Uncomplicated Plasmodium Falciparum MalariaCompletedNCT03660839Phase 2
- Efficacy and Safety of KAF156 in Combination With LUM-SDF in Adults and Children With Uncomplicated Plasmodium Falciparum MalariaCompletedNCT03167242Phase 2
- Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric PatientsCompletedNCT00541385Phase 3
- Safety of KAE609 in Adults With Uncomplicated Plasmodium Falciparum Malaria.CompletedNCT03334747Phase 2
- Safety, Tolerability and Protective Efficacy of PfSPZ Vaccine in Gabonese ChildrenCompletedNCT03521973Phase 2
- Human Soil Transmitted Helminths (STH) Resistance to Benzimidazole in School Aged Children Living in GabonCompletedNCT04326868Phase 4
- Schistosomiasis Diagnosis Using a CAA Antigen TestStatus unknownNCT03779347Phase 3
- Validation of Promising Biomarker Assays to Assess Their Diagnostic Performance CharacteristicsCompletedNCT03047642
- Na-GST-1/Alhydrogel With or Without CpG 10104 in Gabonese AdultsCompletedNCT03373214Phase 1
- Comparing the Effectiveness of Individual vs. Household Treatment for Scabies in Lambaréné, GabonCompletedNCT04205669Phase 4
- Assessing the Effect of Neglected Tropical Diseases on Plasmodium Falciparum Transmission in an Area of Co-endemicityCompletedNCT02769013
- Epidemiology Study of Malaria Transmission Intensity in AfricaCompletedNCT01190202Not applicable
- Validation of INSPiRED Innovative Smart Diagnostic Devices for the Detection of Parasites Infections.Status unknownNCT04505046
- Effect of Artemisinin-based Combination Therapies on Schistosomiasis on Malaria Co-infectionCompletedNCT04264130Phase 2
- Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in AfricaCompletedNCT00866619Phase 3
- Cohort Event Monitoring Study of Pyramax®CompletedNCT03201770Phase 4
- Mifepristone and Misoprostol Versus Misoprostol Alone for Missed Abortion: A Randomized-controlled TrialTerminatedNCT02342002Phase 4
- Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI RegimenCompletedNCT00436007Phase 2